SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021019
Filing Date
2024-05-22
Accepted
2024-05-22 16:30:39
Documents
14
Period of Report
2024-05-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44125
  Complete submission text file 0001493152-24-021019.txt   268213

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20240517.xsd EX-101.SCH 3967
3 XBRL DEFINITION FILE bfri-20240517_def.xml EX-101.DEF 26984
4 XBRL LABEL FILE bfri-20240517_lab.xml EX-101.LAB 37210
5 XBRL PRESENTATION FILE bfri-20240517_pre.xml EX-101.PRE 25604
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6644
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24973757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)